SARS-CoV-2 Nucleocapsid 抗体 (C-Term)
Quick Overview for SARS-CoV-2 Nucleocapsid 抗体 (C-Term) (ABIN7272991)
抗原
See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
交叉反应 (详细)
- Reacts with SARS-CoV-2 protein
-
纯化方法
- Epitope affinity purified
-
免疫原
- Affinity purified recombinant fusion protein using the C-terminal of Nucleocapsid (residues 280 to stop) and produced in E. coli
-
亚型
- IgG
-
-
-
-
应用备注
- WB:1:500-1:2,000
-
说明
-
In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
-
限制
- 仅限研究用
-
-
-
浓度
- 3 mg/mL
-
缓冲液
- PBS, 20 % glycerol and 0.05 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at -20 °C for long-term storage. Store at 2-8 °C for up to one month.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
别名
- Nucleocapsid (SARS-CoV-2)
-
物质类
- Viral Protein
抗原
-